FDA approves standalone use of J&J’s ketamine-derived ... - CNN
5 days ago · The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe …
SPRAVATO - Johnson & Johnson
5 days ago · You may report side effects to Johnson & Johnson at 1-800-526-7736, or to the FDA at 1-800-FDA-1088. Please see full Prescribing Information, including Boxed WARNINGS, and …
J&J's ketamine-derived nasal spray approved by FDA to treat …
5 days ago · The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. …
FDA-Approved Nasal Spray For Depression Is First Of Its Kind
3 days ago · A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US. The FDA first approved the Johnson & …
FDA approves Johnson & Johnson’s ketamine-derived nasal …
3 days ago · FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment. Beth Greenfield. Updated Thu, January 23, 2025 at 3:48 PM UTC. 2 …
Johnson & Johnson ketamine-derived nasal spray gets FDA …
5 days ago · Johnson & Johnson beat analyst expectations for revenue by $70 million, but highlighted possible negative impacts in its outlook from an ongoing talc lawsuit and slower …
FDA approves Johnson & Johnson nasal spray Spravato for …
5 days ago · Spravato is now the first-ever stand-alone therapy for treatment-resistant depression, and is on its way to becoming a blockbuster product.
Ketamine-Derived Nasal Spray Approved as Standalone …
4 days ago · This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that …
FDA approves first-of-its-kind nasal spray for severe depression
5 days ago · Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive …
FDA approves Johnson & Johnson’s ketamine-derived nasal …
4 days ago · FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as standalone treatment. Beth Greenfield. January 22, 2025 at 8:28 PM.